Schroder Investment Management Group Cure Vac N.V. Transaction History

Schroder Investment Management Group

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$13.18 - $19.41 $933,974 - $1.38 Million	-70,863 Reduced 87.6%	10,035 $139,000
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $584,663 - $1.4 Million	39,692 Added 96.33%	80,898 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $1.39 Million - $1.99 Million	41,206 New	41,206 $1.41 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.